medigraphic.com
ISSN 1560-4381 (Print)

2015, Number 2

<< Back Next >>

Correo Científico Médico 2015; 19 (2)

Idiopathic intracranial hypertension: main neurophysiological, diagnosis and therapeutic features

Rodríguez PJM, Díaz RYV, Rojas RY, Núñez AE, García GA

Language: Spanish
References: 40
Page: 282-299
PDF size: 442.98 Kb.


ABSTRACT

Idiopathic intracranial hypertension, also known as pseudotumor cerebri is a condition characterized by increased intracranial pressure, not caused to mass lesions or focal structural abnormalities, or with normal composition of the cerebrospinal fluid. Ventricles can be observed normal or small in imaging studies. Its etiology and pathogenesis are unknown. Idiopathic intracranial hypertension is an avoidable cause of visual loss, in both adults and children. Treatment is usually effective, and most patients have observed complete resolution of symptoms without persistent deficits.


REFERENCES

  1. Asensio Sánchez VM, Merino Angulo J, Martínez Calvo S, Calvo MJ, Rodríguez R. Epidemiología del pseudotumor cerebral. Arch Soc Esp Oftalmol. 2007 [citado 12 nov 2014]; 82(4). Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912007000400006

  2. Pearce JM. From pseudotumour cerebri to idiopathic intracranial hypertension. Practical Neurol. 2009 [citado 12 nov 2014]; 9(6). Disponible en: https://www.clinicalkey.es/#!/content/medline/2-s2.0-19923117

  3. Sardiñas Hernández N, Casanova Sotolongo P. Historia y definición. En: Hipertensión endocraneana benigna. La Habana: Editorial Pueblo y Educación; 1991.p.1-3.

  4. Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985 [citado 12 nov 2014]; 5. Disponible en: www.ncbi.nlm.nih.gov/pubmed/3156890

  5. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002 [citado 12 nov 2014]; 59. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/12455560

  6. Bruce BB, Kedar S, Van Stavern GP, Corbett JJ, Newman NJ, Biousse V. Atypical idiopathic intracranial hypertension: normal BMI and older patients. Neurol. 2010; 74(22):1827–32. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882219/7. Bruce BB, Kedar S, Van Stavern GP. Idiopathic intracranial hypertension in men. Neurol. 2009 [citado 12 nov 2014]; 72(4). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677502/

  7. Brara SM, Koebnick C, Porter AH, Langer Gould A. Pediatric idiopathic intracranial hypertension and extreme childhood obesity. J Pediatrics. 2012 [citado 12 nov 2014]; 161(4). Disponible en: http://www.jpeds.com/article/S0022-3476%2812%2900356-3/pdf

  8. Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2012 [citado 12 nov 2011]; 83(5). Disponible en: www.ncbi.nlm.nih.gov/pubmed/22423118

  9. Rosenberg GA. Brain edema and disorders of cerebrospinal fluid circulation. En: Daroff RB, Fenichel GM, Jankovic J, Mazziotta JC. Bradley’s Neurology in clinical practice. Philadelphia: Elsevier Saunders; 2012. p.1377-95.

  10. Gobel H, Gobel C, Heinze A. Headache from increased cerebrospinal fluid pressure. Schmerz. 2012 [citado 12 nov 2011]; 26(3). Disponible en: http://europepmc.org/abstract/med/22760466

  11. Skau M, Goetze JP, Rehfeld JF, Jensen R. Natriuretic propeptides in idiopathic intracranial hypertension. Regulatory peptides. 2010 [citado 12 nov 2014]; 164(23). Disponible en: http://www.sciencedirect.com/science/article/pii/S0167011510001175

  12. Bateman GA. Association between arterial inflow and venous outflow in idiopathic and secondary intracranial hypertension. J Clin Neurosci. 2006 [citado 12 nov 2013]; 13(5). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/16540323

  13. Bateman GA. Idiopathic intracranial hypertension: priapism of the brain? Medical hypotheses. 2004 [citado 12 nov 2013]; 63(3). Disponible en: www.journals.elsevierhealth.com/.../article/.../fulltext

  14. 15 Fraser C, Plant GT. The syndrome of pseudotumour cerebri and idiopathic intracranial hypertension. Current Opinion in Neurology. 2011 [citado 12 dic 2013]; 24(1). Disponible en: http://journals.lww.com/co-neurology/Abstract/2011/02000/16. Ko MW, Liu GT. Pediatric idiopathic intracranial hypertension (pseudotumor cerebri). Hormone research in paediatrics. 2010 [citado 1 nov 2014]; 74(6). Disponible en: www.karger.com/Article/Abstract/321180

  15. Moser FG, Hilal SK, Abrams G, Bello JA, Schipper H, Silver AJ. MR imaging of pseudotumor cerebri. AJR. 1988 [citado 16 nov 2013]; 150(4). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25358812

  16. Lin J, Fernandes JK, Faria EC, Pinho RS, Masruha MR, Vilanova LC. Fulminant idiopathic intracranial hypertension in a pediatric patient following a minor head trauma. Arquivos de neuro-psiquiatria. 2009 [citado 12 dic 2013]; 67(2). Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2009000300030&lng=en&nrm=iso&tlng=en

  17. Santos S, López del Val LJ, Pascual LF, Mostacero E, Tejero C, Casadevall T, et al. Pseudotumor cerebral: análisis de nuestra casuística y revisión de la literatura. Rev Neurol. 2001 [citado 12 dic 2013]; 33 (12). Disponible en: http://www.revneurol.com/sec/resumen.php?or=web&i=e&id=2001346

  18. Spennato P, Ruggiero C, Parlato RS, Buonocore MC, Varone A, Cianciulli E, et al. Pseudotumor cerebri. Childs Nerv Syst. 2011[citado 22 dic 2013]; 27(2). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=Spennato+P%2C+Ruggiero+C%2C+Parlato+RS%2C+Buonocore+MC%2C+Varone+A%2C+Cianciulli+EP.seudotumor+cerebri

  19. González Hernández A, Fabre Pi O, Díaz Nicolás S, López Fernández JC, López Veloso C, Jiménez Mateos A. Cefalea en la hipertensión intracraneal idiopática. Rev Neurol. 2009 [citado 12 dic 2011]; 49(1). Disponible en: http://neurologia.com/pdf/Web/4901/bc010017.pdf

  20. Hacifazlioglu Eldes N, Yilmaz Y. Pseudotumour cerebri in children: Etiological, clinical features and treatment modalities. European J Paediatric Neurol. 2012 [citado 12 dic 2012]; 16(4):1808-1813. Disponible en: http://www.ejpn-journal.com/article/S1090-3798%2811%2900188-7/abstract?cc=y

  21. Standridge SM. Idiopathic intracranial hypertension in children: a review and algorithm. Pediatr Neurol. 2010 [citado 12 dic 2012]; 43(6). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21093727

  22. Ney JJ, Volpe NJ, Liu GT, Balcer LJ, Moster ML, Galetta SL. Functional visual loss in idiopathic intracranial hypertension. Ophthalmology. 2009 [citado 12 dic 2011]; 116(9). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19643491

  23. Hernández Flores ZG. Análisis retrospectivo de pacientes diagnosticados con hipertensión intracraneal idiopática al ingreso. Evaluación del abordaje diagnóstico. Medigraphic. 2010 [citado 12 oct 2014]; 2(3): 35-42. Disponible en: http://new.medigraphic.com/cgi-bin/resumenMain.cgi?IDARTICULO=32504&IDPUBLICACION=3520&IDREVISTA=240

  24. Liu GT, Volpe NJ, Galetta SL. Optic disc swelling: papilledema and other causes. En: Neuro-Ophthalmology: Diagnosis and management. 2ed. Philadelphia: Elsevier Saunders; 2010. p.199-236.

  25. Thurtell MJ, Newman NJ, Biousse V. Visual loss without papilledema in idiopathic intracranial hypertension. J Neuroophthalmol. 2010 [citado 22 oct 2014]; 30(1). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20182218

  26. Heidary G, Rizzo JF. Use of optical coherence tomography to evaluate papilledema and pseudopapilledema. Semin Ophthalmol. 2010 [citado 22 oct 2014]; 25(5): 195-205 Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21091000

  27. Obeid T, Awada A, Mousali Y, Nusair M, Muhayawi S, Memish S. Extensive radiculopathy: a manifestation of intracranial hypertension. Eur J Neurol. 2000 [citado 20 oct 2014]; 7(5): 549-53. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/11054141

  28. Skau M, Brennum J, Gjerris F, Jensen R. What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia. 2006 [citado 22 oct 2014]; 26(4): 384-399. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1468-2982.2005.01055.x/abstract

  29. Mayer SA, Fishman RA. Brain Edema and Disorders of Intracranial Pressure. En: Rowland LP, Pedley TA. Merritt's Neurology. 12 ed. New York: Ed. Lippincott & Williams;2010.p.359-366.

  30. Ropper AH, Samuels A. Trastornos del líquido cefalorraquídeo: circulación, hidrocefalia, seudotumor cerebral y síndromes de presión baja. En: Adams & Victors' Principles of Neurology. 9ed. Philadelphia: McGraw-Hill; 2009. p.591-611.33. Faz G, Butler IJ, Koenig MK. Incidence of papilledema and obesity in children diagnosed with idiopathic ‘’benign’’ intracranial hypertension: case series and review. J Child Neurol. 2010 [citado 22 oct 2014]; 25(11): 1389-1392. Disponible en: http://jcn.sagepub.com/content/25/11/1389.long

  31. Friedman DI. Idiopathic intracranial hypertension with Dan and beyond: the 2010 Jacobson Lecture. J Neuro-Ophthalmol. 2010 [citado 12 oct 2014]; 30(4). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21107127

  32. Plant G, Acheson J, Clarke Ch, Graham E, Howard R, Shorvon S. Neuro-Ophthalmology. En: Clarke Ch, Howard R, Rossor M, Shorvon S. Neurology: A Queen Square Textbook. London: Wiley-Blackwell; 2009.p. p.489-532.

  33. Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010; 341. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=Low+energy+diet+and+intracranial+pressure+in+women+with+idiopathic+intracranial+hypertension%3A+prospective+cohort+study.

  34. Wall M. Idiopathic intracranial hypertension. Neurol Clin. 2010 [citado 22 oct 2014]; 28(3) Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20637991

  35. Tomsak RL, Niffenegger AS, Remler BF. Treatment of pseudotumorcerebri with Diamox (acetazolamide).J Clin Neuroophthalmol. 1988 [citado 22 oct2014]; 8(2). Disponible en: www.spoftalmologia.pt/wp.../12/Livro-Neuroftalmologia-JUL14-v19.pdf

  36. Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vsacetazolamide, an open-label study. Act Neurol Scandinavica. 2007 [citado 22 oct 2014]; 116(5):322-7. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0404.2007.00905.x/pdf

  37. Lorrot M, Bader Meunier B, Sebire G, Dommergues JP. Benign intracranial hypertension: an unrecognized complication of corticosteroidtherapy. Arch Pediatr. 1999 [citado 11 oct 2014]; 6(1):40-2. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=40.%09Lorrot+M%2C+Bader+Meunier+B%2C+Sebire+G%2C+Dommergues+JP.+Benign+intracranial+hypertension%3A+an+unrecognized+complication+of+corticosteroidtherapy

  38. Thurtell MJ, Wall M. Idiopathic Intracranial Hypertension (Pseudotumor Cerebri): Recognition, Treatment, and Ongoing Management. Curr Treat Options Neurol. 2013 [citado 12 oct 2014]; 15(1): 1–12. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554852/

  39. Wilkes BN, Siatkowski RM. Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration. J Neuroophthalmol. 2009 [citado 22 oct 2014]; 29(4). Disponible en: http://journals.lww.com/jneuro-ophthalmology/Fulltext/2009/12000/Progressive_Optic_Neuropathy_in_Idiopathic.3.aspx#

  40. Polo Torres C, Alvis Miranda HR, Castellar Leones SM, Moscote Salazar MA, Alcalá Cerra G, Moscote Salazar LR. Patobiología de la hipertensión intracraneal idiopática infantil. Rev Chil Neurocirug. 2013 [citado 22 oct 2014]; 39:45-56. Disponible en: http://neurocirugia.cl/new/images/revistas/rev_39_1/7-Polo-Torres.pdf




2020     |     www.medigraphic.com